Proceedings of the 3rd International Conference on Big Data Economy and Digital Management, BDEDM 2024, January 12–14, 2024, Ningbo, China

Research Article

Revolutionary Integration of AI in Drug Development: A Comprehensive Analysis

Download42 downloads
  • @INPROCEEDINGS{10.4108/eai.12-1-2024.2347179,
        author={Jiayu  Fang and Haoyu  Bian and Jingyan  Wu and Hanyu  Pei and Pu  Du},
        title={Revolutionary Integration of AI in Drug Development: A Comprehensive Analysis},
        proceedings={Proceedings of the 3rd International Conference on Big Data Economy and Digital Management, BDEDM 2024, January 12--14, 2024, Ningbo, China},
        publisher={EAI},
        proceedings_a={BDEDM},
        year={2024},
        month={6},
        keywords={artificial intelligence in drug development ai-assisted diagnostics multi-omics data analysis advancement in personalized medicine technological shift in the pharmaceutical industry},
        doi={10.4108/eai.12-1-2024.2347179}
    }
    
  • Jiayu Fang
    Haoyu Bian
    Jingyan Wu
    Hanyu Pei
    Pu Du
    Year: 2024
    Revolutionary Integration of AI in Drug Development: A Comprehensive Analysis
    BDEDM
    EAI
    DOI: 10.4108/eai.12-1-2024.2347179
Jiayu Fang1, Haoyu Bian2,*, Jingyan Wu3, Hanyu Pei4, Pu Du5
  • 1: University of Sydney
  • 2: Nanjing University
  • 3: The University of Warwick
  • 4: Wuhan University of Technology
  • 5: Tianjin Vocational College of Sports
*Contact email: 2482516799@qq.com

Abstract

Artificial Intelligence (AI) is revolutionizing drug development, introducing significant advancements in diagnostics, drug information analysis, and multi-omics data interpretation. AI's role in diagnostics is streamlining drug information collection, leading to enhanced decision-making and the development of more personalized medications. In drug design, AI's ability to analyze vast biological datasets is accelerating the discovery of new drug targets and pathways, making the research process more efficient and cost-effective. While the integration of AI in pharmaceutical research presents challenges such as data quality and ethical considerations, its potential for transforming drug development is immense. This technological shift promises a new era in healthcare, with AI-driven innovations paving the way for breakthroughs in disease treatment and patient care.